Page 349 - Small Caps News Today

Brokers raise valuations for Neuren Pharmaceuticals following positive Phase 2 clinical trial results

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

The Fed's signal that it could soon start slashing interest rates is great news for small-cap stocks, according to the bank's CIO Mike Wilson.

The overall market undertone remains positive but volatility could increase as valuations go up, cautions Upadhyaya

Next year should bring a continued focus on AI, with Nvidia again leading the way. The big change is likely to be the return of IPOs.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

De Document Foundation is sinds juni bezig met de ontwikkeling van de volgende generatie van LibreOffice en heeft nu de eerste bètarelease uitgebracht.

The smallest microcap stocks, which should benefit most from a sunnier economy, are still remarkably inexpensive. Here are some funds to ride a possible boom.

Barry Knapp of Ironsides Macroeconomics tells Quartz the portfolio adjustments you should make right now to protect yourself going into 2024